Cognitive Behavioral Therapy for Cancer Anxiety
(CBT-FCRBRCA1/2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how cognitive-behavioral therapy (CBT) can assist women with a BRCA1/2 genetic mutation who worry about cancer recurrence. The researchers aim to determine if this therapy can reduce their fear of cancer returning and improve overall well-being, such as decreasing anxiety and enhancing sleep. Participants will either begin therapy immediately or after a short delay. Women who have completed treatment for breast or ovarian cancer and can speak French may qualify. As an unphased trial, this study provides a unique opportunity for participants to contribute to innovative research that could enhance support for women with similar concerns.
What prior data suggests that this cognitive-behavioral therapy protocol is safe for cancer survivors?
Research has shown that cognitive-behavioral therapy (CBT) is generally safe and well-tolerated by patients. Studies have found that CBT can significantly enhance mental health and quality of life for cancer patients, with moderate improvements observed in various trials. For example, one study found that CBT reduced anxiety and depression in cancer patients within a few weeks. Another study showed that CBT improved the mental well-being of glioma patients undergoing chemotherapy.
Additionally, group CBT has effectively reduced mental distress, especially among women with breast cancer. Most participants in these studies reported significant improvements, with benefits lasting up to 26 weeks. These findings suggest that CBT is a safe option for managing anxiety and related issues in cancer survivors.12345Why are researchers excited about this trial?
Cognitive-behavioral group therapy is unique because it specifically targets the anxiety experienced by cancer patients through structured group sessions. Unlike traditional treatments such as medication or individual therapy, this approach leverages the power of group dynamics, providing peer support and shared experiences which can enhance coping strategies. Researchers are excited about this treatment because it offers a non-pharmacological option that could reduce anxiety symptoms without the potential side effects of medication, and it empowers patients by equipping them with practical skills to manage their anxiety more effectively.
What evidence suggests that this cognitive-behavioral group therapy is effective for reducing fear of cancer recurrence?
Research shows that cognitive-behavioral therapy (CBT) helps reduce anxiety and depression in cancer patients. Studies have found that CBT improves mental health and quality of life for these individuals. One study found that CBT greatly reduced psychological symptoms in cancer patients. Another study showed that people who participated in group CBT experienced less anxiety and depression during follow-up check-ins. In this trial, participants will either receive immediate intervention with CBT or be placed on a waiting list before starting the same intervention. Overall, CBT provides important emotional and psychological benefits for cancer survivors, making it a promising option for those facing cancer-related anxiety.12678
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 7 weekly group CBT sessions for fear of cancer recurrence
Follow-up
Participants are monitored for safety and effectiveness after treatment
Waitlist Control
Participants in the waitlist condition wait for 7 weeks before starting the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive-behavioral group therapy
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
This group will start as soon as between 5-8 persons have been recruited and randomized into the immediate intervention group.
This group will wait for 7 weeks after being recruited before starting the same intervention as the immediate intervention group.
Find a Clinic Near You
Who Is Running the Clinical Trial?
CHU de Quebec-Universite Laval
Lead Sponsor
Citations
The efficacy of cognitive behavioral therapy for mental health ...
CBT statistically improves the MH and QoL psychosocial parameters in cancer patients with greater efficacy in younger patients.
2559P Effectiveness of cognitive behavioral therapy in ...
Conclusions. CBT significantly reduced psychological symptoms in patients with cancer. These findings support integrating validated psychological screening ...
Cognitive behavioral therapy for anxiety and depression in ...
This study aimed to investigate the effects of cognitive behavioral therapy (CBT) on anxiety and depression in cancer survivors.
Effects of cognitive behavioral therapy on anxiety and ...
Cognitive behavioral therapy lasting for 2–8 weeks is effective for anxiety and depressive symptoms in advanced cancer patients to a moderate degree.
5.
targetedonc.com
targetedonc.com/view/cbt-benefits-cancer-patients-mental-health-treatment-adherenceCBT Benefits Cancer Patients' Mental Health and ...
Cognitive behavioral therapy (CBT) offers significant benefits for patients with cancer by addressing the emotional and psychological challenges that often ...
The impact of cognitive behavioral therapy on disease ... - PMC
The study revealed that the group that received CBT showed significant improvements in the psychological well-being of glioma patients undergoing chemotherapy.
Effects of cognitive behavioral therapy on resilience among ...
The results of this study indicate CBT can improve resilience among cancer patients. These findings underscore the importance of considering ...
A Randomized Clinical Trial - Jefferson Digital Commons
PURPOSE Anxiety is prevalent, disruptive, and undertreated among survivors of cancer. Cognitive behavioral therapy (CBT) is the first-line ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.